Related Experiment Video
Updated: Jul 23, 2025

06:57
Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects
Published on: February 12, 2021
3.3K
Asthma as a Systemic Disease: Cardiovascular Effects Associated with Asthma
1University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. tattersall@wisc.edu.
Advances in Experimental Medicine and Biology
|July 18, 2023
Summary
Asthma patients face higher cardiovascular disease (CVD) risks due to systemic inflammation. Identifying high-risk individuals with asthma is crucial for targeted prevention and treatment of CVD.
Area of Science:
- Pulmonary Medicine
- Cardiology
- Public Health
Background:
- Asthma and cardiovascular disease (CVD) are major public health concerns.
- Systemic inflammation in asthma contributes to CVD pathophysiology.
- Epidemiological studies link asthma to adverse cardiovascular outcomes like arterial injury, atherosclerotic events, atrial fibrillation, and hypertension.
Purpose of the Study:
- To explore the complex relationship between asthma and CVD risk.
- To address the heterogeneity of CVD risk across asthma phenotypes and endotypes.
- To emphasize the need for a precision medicine approach in managing CVD risk in asthma patients.
Main Methods:
- Review of epidemiological studies and pathophysiological mechanisms.
- Analysis of cardiovascular effects associated with asthma.
- Examination of clinical phenotypes and molecular endotypes of asthma.
Main Results:
- Asthma is associated with increased risk of various cardiovascular diseases.
- CVD risk is not uniform across all asthma subtypes.
- Mechanisms linking asthma and CVD are multifactorial and not fully understood.
Conclusions:
- A precise approach is needed to identify asthma patients at high risk for CVD.
- Targeted diagnostic and preventive strategies are essential to reduce CVD burden in asthma.
- Further research is required to elucidate the multifactorial mechanisms underlying CVD risk in asthma.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
449
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
449
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists
310
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
310

